Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Last Updated: May 29, 2023

Watson Labs Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for WATSON LABS INC, and what generic and branded alternatives to WATSON LABS INC drugs are available?

WATSON LABS INC has seventy-six approved drugs.

There are eleven tentative approvals on WATSON LABS INC drugs.

Summary for Watson Labs Inc
US Patents:0

Drugs and US Patents for Watson Labs Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc ROSUVASTATIN CALCIUM rosuvastatin calcium TABLET;ORAL 079167-002 Apr 29, 2016 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Watson Labs Inc CEFACLOR cefaclor FOR SUSPENSION;ORAL 064205-001 Feb 18, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Watson Labs Inc DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM drospirenone; ethinyl estradiol; levomefolate calcium TABLET;ORAL 203594-001 Oct 11, 2016 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Watson Labs Inc OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 062856-005 Oct 26, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Watson Labs Inc CELECOXIB celecoxib CAPSULE;ORAL 200562-003 Feb 11, 2015 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Watson Labs Inc IRBESARTAN irbesartan TABLET;ORAL 090720-002 Oct 12, 2012 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.